Who are RAPT Therapeutics's investors?

RAPT Therapeutics's investors include Foresite Capital, Frazier Life Sciences, GV (Google Ventures), Kleiner Perkins, Medicxi, Solasta Ventures, The Column Group, OrbiMed.

Who acquired RAPT Therapeutics?

RAPT Therapeutics was acquired by GSK.

RAPT Therapeutics

Unicorn exit · $2.2Bacquired by GSK

Founded 2015 · 120 employees on LinkedIn · 8 known investors

Find your way into RAPT Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the RAPT Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by GSK January 2026 · $2.2B ($58.00 per share, ~$2.2 billion aggregate equity value) · source ↗

RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases. Its pipeline includes ozureprubart, a long-acting anti-IgE antibody being developed for food allergy.

Biotech Healthtech

Investors · 8

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M

How we know: GV (Google Ventures)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Kleiner Perkinslisted by Kleiner PerkinsMenlo Park · $500K – $15M

How we know: Kleiner Perkins's portfolio page · Not right? Tell us

Medicxilisted by MedicxiLondon

How we know: Medicxi's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Solasta Ventureslisted by Solasta VenturesBoston

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

The Column Grouplisted by The Column GroupSan Francisco · $30M

How we know: The Column Group's portfolio page · the VCSheet dataset · Not right? Tell us

OrbiMedreportedNew York · $1M – $75M

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountprivate placementDec 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through RAPT Therapeutics went on to found or lead other companies.

Wendye RobbinsMember Board of Directors, Audit, Transaction, and Pricing CommitteesFounded Limerick Biopharma +1 Dennis X. HuScientist I, Drug DiscoveryFounded Drug Hunter

In the news

RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September - RAPT Therapeuticsrapt.com · Sep 2023

Frequently asked questions

What does RAPT Therapeutics do?: RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases. Its pipeline includes ozureprubart, a long-acting anti-IgE antibody being developed for food allergy.
Who are RAPT Therapeutics's investors?: RAPT Therapeutics's investors include Foresite Capital, Frazier Life Sciences, GV (Google Ventures), Kleiner Perkins, Medicxi, Solasta Ventures, The Column Group, OrbiMed.
Who acquired RAPT Therapeutics?: RAPT Therapeutics was acquired by GSK.